Live feed04:30:00·14mNEWSReleasevia QuantisnowPreliminary Results of Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar Health's Crofelemer Accepted for Presentation at Annual American College of Gastroenterology MeetingByQuantisnow·Wall Street's wire, on your screen.JAGX· Jaguar Health Inc.Health Care
